New blood and urine tests could spot kidney rejection early
NCT ID NCT01531257
First seen May 06, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study aims to find better ways to monitor kidney transplant recipients for signs of rejection or long-term damage. Current tests like creatinine levels are not sensitive enough to catch early problems. Researchers will collect blood, urine, and tissue samples from 1,000 participants during routine biopsies to validate new biomarker panels. The goal is to develop less invasive and more accurate monitoring tools to improve transplant outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE REJECTION (AR) OF TRANSPLANTED KIDNEY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.